Regulators finally back Merck KGaA oral MS drug
June 26, 2017
Spry Health raises funds for clinical-grade wearable
June 26, 2017Spry Health’s Loop aims to improve interventional care for the critically ill.
Wayward Astellas comes close to UK industry expulsion
June 26, 2017
Trump plan aims to be pro-pharma and cut drug prices
June 22, 2017
Immuno-oncology drugs: key to the Cancer Moonshot?
June 21, 2017Assessing the global challenges inhibiting immuno-oncology market access.
Meeting the needs of cancer patients and healthcare providers
June 20, 2017Complex and evolving cancer treatment pathways require comprehensive and tailored support programmes.
Pricing and market access – facts versus fiction
January 31, 2017‘Pricing and Market Access Outlook: 2017 Edition’ includes fresh analysis from QuintilesIMS of market forces and pricing policy based on facts and figures behind approvals of new molecular entities in 2015.
Healthcare in the Digital Age
November 22, 2016A new whitepaper presenting analysis of exclusive M3 (EU) data, revealing the digital and technological habits and preferences of doctors and how pharma can best engage.
